What are the types of muscular dystrophy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Muscular Dystrophy

Muscular dystrophies are a group of inherited genetic disorders characterized by progressive muscle weakness and degeneration, with various types affecting different muscle groups and having distinct genetic causes and clinical presentations. 1

Major Types of Muscular Dystrophy

Dystrophinopathies

  • Duchenne Muscular Dystrophy (DMD)

    • X-linked disorder affecting approximately 1 in 5,000 live male births 1
    • Caused by mutations in the dystrophin gene leading to absence of dystrophin protein
    • Presents in early childhood with progressive proximal muscle weakness
    • Associated with significant cardiomyopathy and respiratory failure
    • Without supportive care, death typically occurs in late teens or early twenties 1
  • Becker Muscular Dystrophy (BMD)

    • Milder variant of dystrophinopathy with partial dystrophin expression
    • Later onset and slower progression than DMD
    • Variable cardiac involvement 1, 2

Myotonic Dystrophies

  • Myotonic Dystrophy Type 1 (DM1)

    • Autosomal dominant disorder caused by CTG repeat expansion
    • Characterized by myotonia (delayed muscle relaxation), muscle weakness, and multisystem involvement
    • Cardiac conduction defects common 1, 2
  • Myotonic Dystrophy Type 2

    • Similar to DM1 but generally milder with later onset 2

Facioscapulohumeral Muscular Dystrophy (FSHD)

  • Typically affects face, shoulder girdle, and upper arms
  • Autosomal dominant inheritance
  • Variable progression and severity 1, 2

Limb-Girdle Muscular Dystrophies (LGMD)

  • Heterogeneous group with multiple subtypes
  • Primarily affects shoulder and pelvic girdles
  • Can be autosomal dominant (type 1) or recessive (type 2)
  • Cardiac involvement varies by subtype 1
  • Some forms (types 2C, 2F, and 2I) present primarily as non-ischemic cardiomyopathy 1

Emery-Dreifuss Muscular Dystrophy (EDMD)

  • Characterized by early contractures, slowly progressive muscle weakness, and cardiac involvement
  • X-linked, autosomal dominant, or autosomal recessive inheritance
  • Associated with Lamin A/C mutations in some forms
  • High risk of sudden cardiac death due to conduction defects and arrhythmias 1
  • ICD placement may be indicated for primary prevention 1

Congenital Muscular Dystrophies

  • Present at birth or early infancy
  • Multiple subtypes with varying severity
  • Often associated with brain and eye abnormalities
  • Some forms have significant cardiac involvement 1

Other Types

  • Oculopharyngeal Muscular Dystrophy

    • Late-onset disorder affecting eyelid and throat muscles
    • Minimal cardiac involvement 1
  • Distal Muscular Dystrophies

    • Primarily affect distal limb muscles (hands, forearms, lower legs)
    • Various genetic causes 2

Clinical Significance and Management

Cardiac Involvement

  • Varies significantly between different types of muscular dystrophy
  • Some types primarily cause cardiomyopathy (DMD, BMD, some LGMDs)
  • Others primarily cause conduction defects and arrhythmias (EDMD, LGMD1B, DM1)
  • Some affect both (Barth syndrome, myofibrillar myopathies) 1
  • Regular cardiac monitoring is essential in most forms 1

Genetic Testing

  • Critical for definitive diagnosis and genetic counseling
  • Allows for precise subtype classification
  • Guides cardiac surveillance and management strategies
  • May identify candidates for emerging gene-specific therapies 1

Monitoring Recommendations

  • Regular cardiac assessment is recommended even in asymptomatic patients with muscular dystrophy 1
  • ICD placement should be considered in high-risk subtypes such as EDMD and LGMD1B 1
  • Primary and secondary prevention ICDs are recommended for patients with neuromuscular disorders using the same indications as for non-ischemic cardiomyopathy if meaningful survival greater than 1 year is expected 1

Diagnostic Approach

  • Muscle biopsy remains an important diagnostic tool for distinguishing inflammatory from non-inflammatory myopathies 1
  • Genetic testing is increasingly the gold standard for definitive diagnosis 1
  • Electromyography helps confirm myopathic processes and target muscles for biopsy 1
  • Cardiac imaging (echocardiography, cardiac MRI) is important for detecting cardiac involvement 1

The prevalence of different muscular dystrophy types varies by population, with Duchenne dystrophy, limb-girdle dystrophy, and Becker dystrophy being among the most common forms in many populations 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The muscular dystrophies.

Continuum (Minneapolis, Minn.), 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.